Cue Biopharma, Inc.
Ticker: 1645460
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 5.69+164.7% | 2.15-27.1% | 2.95+602.4% | 0.42-87.4% | 3.34+25.6% | 2.66+54.7% | 1.72-18.1% | 2.10 |
| Total Income | 5.69+164.7% | 2.15-27.1% | 2.95+602.4% | 0.42-87.4% | 3.34+25.6% | 2.66+54.7% | 1.72-18.1% | 2.10 |
| EXPENSES | ||||||||
| Expenditure | 11.04+13.3% | 9.74-16.0% | 11.59-8.9% | 12.72+4.7% | 12.15-6.8% | 13.04-9.4% | 14.39+6.4% | 13.52 |
| PROFIT | ||||||||
| Net Profit | -5.18+30.5% | -7.45+12.1% | -8.48+30.8% | -12.26-41.6% | -8.66+14.8% | -10.17+17.7% | -12.35-12.2% | -11.01 |
| KEY METRICS | ||||||||
| OPM % | -94.14%+5.85pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -91.07%+8.93pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.08-1442.9% | -0.07+22.2% | -0.09+47.1% | -0.17+0.0% | -0.17+15.0% | -0.20+20.0% | -0.25-4.2% | -0.24 |
Corporate Events
Board MeetingCUE
20261Jun
Board Meeting
Stockholders will vote on the approval of the issuance of sh…
SEC Filing ↗ Board MeetingCUE
202629May
Board Meeting
Board and Officer Changes — Jill Broadfoot, Peter Kiener, Fr…
SEC Filing ↗ Board MeetingCUE
20263May
Board Meeting
Appointment of Shao-Lee Lin as President and CEO, and grant …
SEC Filing ↗